Bringing the FDA's Information to Market.
Woloshin
Steven
S
Veterans Affairs Outcomes Group, Veterans Affairs Medical Center, VT 05055, USA.
Schwartz
Lisa M
LM
D016907:Adverse Drug Reaction Reporting Systems; D000329:Advertising / Q000639:trends; D052246:Cyclooxygenase 2 Inhibitors / Q000009:adverse effects*; D004345:Drug Industry; D004348:Drug Labeling / Q000592:standards; D011307:Drug Prescriptions / Q000191:economics; D006801:Humans; D033181:Information Dissemination / Q000379:methods; D007783:Lactones / Q000009:adverse effects*; D015201:Meta-Analysis as Topic; D009203:Myocardial Infarction / Q000139:chemically induced*; D056737:Safety-Based Drug Withdrawals; D013450:Sulfones / Q000009:adverse effects*; D013997:Time Factors; D014481:United States; D014486:United States Food and Drug Administration
D052246:Cyclooxygenase 2 Inhibitors; D007783:Lactones; D013450:Sulfones; C116926:rofecoxib